Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 33 entries
Sorted by: Best Match Show Resources per page
Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.

Oncoimmunology

Espinoza JA, Jabeen S, Batra R, Papaleo E, Haakensen V, Timmermans Wielenga V, Møller Talman ML, Brunner N, Børresen-Dale AL, Gromov P, Helland Å, Kristensen VN, Gromova I.
PMID: 28123884
Oncoimmunology. 2016 Oct 24;5(12):e1248015. doi: 10.1080/2162402X.2016.1248015. eCollection 2016.

The tumor microenvironment is composed of many immune cell subpopulations and is an important factor in the malignant progression of neoplasms, particularly breast cancer (BC). However, the cytokine networks that coordinate various regulatory events within the BC interstitium remain...

Cite
Espinoza JA, Jabeen S, Batra R, et al. Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics. Oncoimmunology. 2016;5(12):e1248015doi: 10.1080/2162402X.2016.1248015.
Espinoza, J. A., Jabeen, S., Batra, R., Papaleo, E., Haakensen, V., Timmermans Wielenga, V., Møller Talman, M. L., Brunner, N., Børresen-Dale, A. L., Gromov, P., Helland, �. �., Kristensen, V. N., & Gromova, I. (2016). Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics. Oncoimmunology, 5(12), e1248015. https://doi.org/10.1080/2162402X.2016.1248015
Espinoza, Jaime A, et al. "Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics." Oncoimmunology vol. 5,12 (2016): e1248015. doi: https://doi.org/10.1080/2162402X.2016.1248015
Espinoza JA, Jabeen S, Batra R, Papaleo E, Haakensen V, Timmermans Wielenga V, Møller Talman ML, Brunner N, Børresen-Dale AL, Gromov P, Helland Å, Kristensen VN, Gromova I. Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics. Oncoimmunology. 2016 Oct 24;5(12):e1248015. doi: 10.1080/2162402X.2016.1248015. eCollection 2016. PMID: 28123884; PMCID: PMC5215081.
Copy Download .nbib Format: NLM
Correction to: A systematic comparison of copy number alterations in four types of female cancer.

BMC cancer

Kaveh F, Baumbusch LO, Nebdal D, Børresen-Dale AL, Lingjærde OC, Edvardsen H, Kristensen VN, Solvang HK.
PMID: 29338700
BMC Cancer. 2018 Jan 16;18(1):80. doi: 10.1186/s12885-017-3766-7.

After publication of the original article [1] the authors found that the article contained an incorrect version of Fig. 4. This does not affect the results and conclusions of the article.

Cite
Kaveh F, Baumbusch LO, Nebdal D, et al. Correction to: A systematic comparison of copy number alterations in four types of female cancer. BMC Cancer. 2018;18(1):80doi: 10.1186/s12885-017-3766-7.
Kaveh, F., Baumbusch, L. O., Nebdal, D., Børresen-Dale, A. L., Lingjærde, O. C., Edvardsen, H., Kristensen, V. N., & Solvang, H. K. (2018). Correction to: A systematic comparison of copy number alterations in four types of female cancer. BMC cancer, 18(1), 80. https://doi.org/10.1186/s12885-017-3766-7
Kaveh, Fatemeh, et al. "Correction to: A systematic comparison of copy number alterations in four types of female cancer." BMC cancer vol. 18,1 (2018): 80. doi: https://doi.org/10.1186/s12885-017-3766-7
Kaveh F, Baumbusch LO, Nebdal D, Børresen-Dale AL, Lingjærde OC, Edvardsen H, Kristensen VN, Solvang HK. Correction to: A systematic comparison of copy number alterations in four types of female cancer. BMC Cancer. 2018 Jan 16;18(1):80. doi: 10.1186/s12885-017-3766-7. PMID: 29338700; PMCID: PMC5769487.
Copy Download .nbib Format: NLM
Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes.

Nature communications

Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, Tsui DW, Liu B, Dawson SJ, Abraham J, Northen H, Peden JF, Mukherjee A, Turashvili G, Green AR, McKinney S, Oloumi A, Shah S, Rosenfeld N, Murphy L, Bentley DR, Ellis IO, Purushotham A, Pinder SE, Børresen-Dale AL, Earl HM, Pharoah PD, Ross MT, Aparicio S, Caldas C.
PMID: 27264733
Nat Commun. 2016 Jun 06;7:11908. doi: 10.1038/ncomms11908.

No abstract available.

Cite
Pereira B, Chin SF, Rueda OM, et al. Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11908doi: 10.1038/ncomms11908.
Pereira, B., Chin, S. F., Rueda, O. M., Vollan, H. K., Provenzano, E., Bardwell, H. A., Pugh, M., Jones, L., Russell, R., Sammut, S. J., Tsui, D. W., Liu, B., Dawson, S. J., Abraham, J., Northen, H., Peden, J. F., Mukherjee, A., Turashvili, G., Green, A. R., McKinney, S., Oloumi, A., Shah, S., Rosenfeld, N., Murphy, L., Bentley, D. R., Ellis, I. O., Purushotham, A., Pinder, S. E., Børresen-Dale, A. L., Earl, H. M., Pharoah, P. D., Ross, M. T., Aparicio, S., & Caldas, C. (2016). Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. Nature communications, 711908. https://doi.org/10.1038/ncomms11908
Pereira, Bernard, et al. "Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes." Nature communications vol. 7 (2016): 11908. doi: https://doi.org/10.1038/ncomms11908
Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, Tsui DW, Liu B, Dawson SJ, Abraham J, Northen H, Peden JF, Mukherjee A, Turashvili G, Green AR, McKinney S, Oloumi A, Shah S, Rosenfeld N, Murphy L, Bentley DR, Ellis IO, Purushotham A, Pinder SE, Børresen-Dale AL, Earl HM, Pharoah PD, Ross MT, Aparicio S, Caldas C. Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. Nat Commun. 2016 Jun 06;7:11908. doi: 10.1038/ncomms11908. PMID: 27264733; PMCID: PMC4897742.
Copy Download .nbib Format: NLM
Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation.

Proceedings of the National Academy of Sciences of the United States of America

Erdélyi K, Ditrói T, Johansson HJ, Czikora Á, Balog N, Silwal-Pandit L, Ida T, Olasz J, Hajdú D, Mátrai Z, Csuka O, Uchida K, Tóvári J, Engebraten O, Akaike T, Børresen Dale AL, Kásler M, Lehtiö J, Nagy P.
PMID: 34737229
Proc Natl Acad Sci U S A. 2021 Nov 09;118(45). doi: 10.1073/pnas.2100050118.

Basal-like breast cancer (BLBC) is the most aggressive subtype of breast tumors with poor prognosis and limited molecular-targeted therapy options. We show that BLBC cells have a high Cys demand and reprogrammed Cys metabolism. Patient-derived BLBC tumors from four...

Cite
Erdélyi K, Ditrói T, Johansson HJ, et al. Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation. Proc Natl Acad Sci U S A. 2021;118(45)doi: 10.1073/pnas.2100050118.
Erdélyi, K., Ditrói, T., Johansson, H. J., Czikora, �. �., Balog, N., Silwal-Pandit, L., Ida, T., Olasz, J., Hajdú, D., Mátrai, Z., Csuka, O., Uchida, K., Tóvári, J., Engebraten, O., Akaike, T., Børresen Dale, A. L., Kásler, M., Lehtiö, J., & Nagy, P. (2021). Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation. Proceedings of the National Academy of Sciences of the United States of America, 118(45), . https://doi.org/10.1073/pnas.2100050118
Erdélyi, Katalin, et al. "Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation." Proceedings of the National Academy of Sciences of the United States of America vol. 118,45 (2021). doi: https://doi.org/10.1073/pnas.2100050118
Erdélyi K, Ditrói T, Johansson HJ, Czikora Á, Balog N, Silwal-Pandit L, Ida T, Olasz J, Hajdú D, Mátrai Z, Csuka O, Uchida K, Tóvári J, Engebraten O, Akaike T, Børresen Dale AL, Kásler M, Lehtiö J, Nagy P. Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation. Proc Natl Acad Sci U S A. 2021 Nov 09;118(45). doi: 10.1073/pnas.2100050118. PMID: 34737229; PMCID: PMC8609449.
Copy Download .nbib Format: NLM
Common variants in breast cancer risk loci predispose to distinct tumor subtypes.

Breast cancer research : BCR

Ahearn TU, Zhang H, Michailidou K, Milne RL, Bolla MK, Dennis J, Dunning AM, Lush M, Wang Q, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Augustinsson A, Baten A, Becher H, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Bojesen SE, Bonanni B, Børresen-Dale AL, Brauch H, Brenner H, Brooks-Wilson A, Brüning T, Burwinkel B, Buys SS, Canzian F, Castelao JE, Chang-Claude J, Chanock SJ, Chenevix-Trench G, Clarke CL, Collée JM, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dörk T, Dwek M, Eccles DM, Evans DG, Fasching PA, Figueroa J, Floris G, Gago-Dominguez M, Gapstur SM, García-Sáenz JA, Gaudet MM, Giles GG, Goldberg MS, González-Neira A, Alnæs GIG, Grip M, Guénel P, Haiman CA, Hall P, Hamann U, Harkness EF, Heemskerk-Gerritsen BAM, Holleczek B, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, Jakimovska M, Jakubowska A, John EM, Jones ME, Jung A, Kaaks R, Kauppila S, Keeman R, Khusnutdinova E, Kitahara CM, Ko YD, Koutros S, Kristensen VN, Krüger U, Kubelka-Sabit K, Kurian AW, Kyriacou K, Lambrechts D, Lee DG, Lindblom A, Linet M, Lissowska J, Llaneza A, Lo WY, MacInnis RJ, Mannermaa A, Manoochehri M, Margolin S, Martinez ME, McLean C, Meindl A, Menon U, Nevanlinna H, Newman WG, Nodora J, Offit K, Olsson H, Orr N, Park-Simon TW, Patel AV, Peto J, Pita G, Plaseska-Karanfilska D, Prentice R, Punie K, Pylkäs K, Radice P, Rennert G, Romero A, Rüdiger T, Saloustros E, Sampson S, Sandler DP, Sawyer EJ, Schmutzler RK, Schoemaker MJ, Schöttker B, Sherman ME, Shu XO, Smichkoska S, Southey MC, Spinelli JJ, Swerdlow AJ, Tamimi RM, Tapper WJ, Taylor JA, Teras LR, Terry MB, Torres D, Troester MA, Vachon CM, van Deurzen CHM, van Veen EM, Wagner P, Weinberg CR, Wendt C, Wesseling J, Winqvist R, Wolk A, Yang XR, Zheng W, Couch FJ, Simard J, Kraft P, Easton DF, Pharoah PDP, Schmidt MK, García-Closas M, Chatterjee N.
PMID: 34983606
Breast Cancer Res. 2022 Jan 04;24(1):2. doi: 10.1186/s13058-021-01484-x.

BACKGROUND: Genome-wide association studies (GWAS) have identified multiple common breast cancer susceptibility variants. Many of these variants have differential associations by estrogen receptor (ER) status, but how these variants relate with other tumor features and intrinsic molecular subtypes is...

Cite
Ahearn TU, Zhang H, Michailidou K, et al. Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Res. 2022;24(1):2doi: 10.1186/s13058-021-01484-x.
Ahearn, T. U., Zhang, H., Michailidou, K., Milne, R. L., Bolla, M. K., Dennis, J., Dunning, A. M., Lush, M., Wang, Q., Andrulis, I. L., Anton-Culver, H., Arndt, V., Aronson, K. J., Auer, P. L., Augustinsson, A., Baten, A., Becher, H., Behrens, S., Benitez, J., Bermisheva, M., Blomqvist, C., Bojesen, S. E., Bonanni, B., Børresen-Dale, A. L., Brauch, H., Brenner, H., Brooks-Wilson, A., Brüning, T., Burwinkel, B., Buys, S. S., Canzian, F., Castelao, J. E., Chang-Claude, J., Chanock, S. J., Chenevix-Trench, G., Clarke, C. L., Collée, J. M., Cox, A., Cross, S. S., Czene, K., Daly, M. B., Devilee, P., Dörk, T., Dwek, M., Eccles, D. M., Evans, D. G., Fasching, P. A., Figueroa, J., Floris, G., Gago-Dominguez, M., Gapstur, S. M., García-Sáenz, J. A., Gaudet, M. M., Giles, G. G., Goldberg, M. S., González-Neira, A., Alnæs, G. I. G., Grip, M., Guénel, P., Haiman, C. A., Hall, P., Hamann, U., Harkness, E. F., Heemskerk-Gerritsen, B. A. M., Holleczek, B., Hollestelle, A., Hooning, M. J., Hoover, R. N., Hopper, J. L., Howell, A., Jakimovska, M., Jakubowska, A., John, E. M., Jones, M. E., Jung, A., Kaaks, R., Kauppila, S., Keeman, R., Khusnutdinova, E., Kitahara, C. M., Ko, Y. D., Koutros, S., Kristensen, V. N., Krüger, U., Kubelka-Sabit, K., Kurian, A. W., Kyriacou, K., Lambrechts, D., Lee, D. G., Lindblom, A., Linet, M., Lissowska, J., Llaneza, A., Lo, W. Y., MacInnis, R. J., Mannermaa, A., Manoochehri, M., Margolin, S., Martinez, M. E., McLean, C., Meindl, A., Menon, U., Nevanlinna, H., Newman, W. G., Nodora, J., Offit, K., Olsson, H., Orr, N., Park-Simon, T. W., Patel, A. V., Peto, J., Pita, G., Plaseska-Karanfilska, D., Prentice, R., Punie, K., Pylkäs, K., Radice, P., Rennert, G., Romero, A., Rüdiger, T., Saloustros, E., Sampson, S., Sandler, D. P., Sawyer, E. J., Schmutzler, R. K., Schoemaker, M. J., Schöttker, B., Sherman, M. E., Shu, X. O., Smichkoska, S., Southey, M. C., Spinelli, J. J., Swerdlow, A. J., Tamimi, R. M., Tapper, W. J., Taylor, J. A., Teras, L. R., Terry, M. B., Torres, D., Troester, M. A., Vachon, C. M., van Deurzen, C. H. M., van Veen, E. M., Wagner, P., Weinberg, C. R., Wendt, C., Wesseling, J., Winqvist, R., Wolk, A., Yang, X. R., Zheng, W., Couch, F. J., Simard, J., Kraft, P., Easton, D. F., Pharoah, P. D. P., Schmidt, M. K., García-Closas, M., & Chatterjee, N. (2022). Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast cancer research : BCR, 24(1), 2. https://doi.org/10.1186/s13058-021-01484-x
Ahearn, Thomas U, et al. "Common variants in breast cancer risk loci predispose to distinct tumor subtypes." Breast cancer research : BCR vol. 24,1 (2022): 2. doi: https://doi.org/10.1186/s13058-021-01484-x
Ahearn TU, Zhang H, Michailidou K, Milne RL, Bolla MK, Dennis J, Dunning AM, Lush M, Wang Q, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Augustinsson A, Baten A, Becher H, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Bojesen SE, Bonanni B, Børresen-Dale AL, Brauch H, Brenner H, Brooks-Wilson A, Brüning T, Burwinkel B, Buys SS, Canzian F, Castelao JE, Chang-Claude J, Chanock SJ, Chenevix-Trench G, Clarke CL, Collée JM, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dörk T, Dwek M, Eccles DM, Evans DG, Fasching PA, Figueroa J, Floris G, Gago-Dominguez M, Gapstur SM, García-Sáenz JA, Gaudet MM, Giles GG, Goldberg MS, González-Neira A, Alnæs GIG, Grip M, Guénel P, Haiman CA, Hall P, Hamann U, Harkness EF, Heemskerk-Gerritsen BAM, Holleczek B, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, Jakimovska M, Jakubowska A, John EM, Jones ME, Jung A, Kaaks R, Kauppila S, Keeman R, Khusnutdinova E, Kitahara CM, Ko YD, Koutros S, Kristensen VN, Krüger U, Kubelka-Sabit K, Kurian AW, Kyriacou K, Lambrechts D, Lee DG, Lindblom A, Linet M, Lissowska J, Llaneza A, Lo WY, MacInnis RJ, Mannermaa A, Manoochehri M, Margolin S, Martinez ME, McLean C, Meindl A, Menon U, Nevanlinna H, Newman WG, Nodora J, Offit K, Olsson H, Orr N, Park-Simon TW, Patel AV, Peto J, Pita G, Plaseska-Karanfilska D, Prentice R, Punie K, Pylkäs K, Radice P, Rennert G, Romero A, Rüdiger T, Saloustros E, Sampson S, Sandler DP, Sawyer EJ, Schmutzler RK, Schoemaker MJ, Schöttker B, Sherman ME, Shu XO, Smichkoska S, Southey MC, Spinelli JJ, Swerdlow AJ, Tamimi RM, Tapper WJ, Taylor JA, Teras LR, Terry MB, Torres D, Troester MA, Vachon CM, van Deurzen CHM, van Veen EM, Wagner P, Weinberg CR, Wendt C, Wesseling J, Winqvist R, Wolk A, Yang XR, Zheng W, Couch FJ, Simard J, Kraft P, Easton DF, Pharoah PDP, Schmidt MK, García-Closas M, Chatterjee N. Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Res. 2022 Jan 04;24(1):2. doi: 10.1186/s13058-021-01484-x. PMID: 34983606.
Copy Download .nbib Format: NLM
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.

Clinical proteomics

Hennessy BT, Lu Y, Gonzalez-Angulo AM, Carey MS, Myhre S, Ju Z, Davies MA, Liu W, Coombes K, Meric-Bernstam F, Bedrosian I, McGahren M, Agarwal R, Zhang F, Overgaard J, Alsner J, Neve RM, Kuo WL, Gray JW, Borresen-Dale AL, Mills GB.
PMID: 21691416
Clin Proteomics. 2010 Dec;6(4):129-51. doi: 10.1007/s12014-010-9055-y.

INTRODUCTION: The lack of large panels of validated antibodies, tissue handling variability, and intratumoral heterogeneity potentially hamper comprehensive study of the functional proteome in non-microdissected solid tumors. The purpose of this study was to address these concerns and to...

Cite
Hennessy BT, Lu Y, Gonzalez-Angulo AM, et al. A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers. Clin Proteomics. 2010;6(4):129-51doi: 10.1007/s12014-010-9055-y.
Hennessy, B. T., Lu, Y., Gonzalez-Angulo, A. M., Carey, M. S., Myhre, S., Ju, Z., Davies, M. A., Liu, W., Coombes, K., Meric-Bernstam, F., Bedrosian, I., McGahren, M., Agarwal, R., Zhang, F., Overgaard, J., Alsner, J., Neve, R. M., Kuo, W. L., Gray, J. W., Borresen-Dale, A. L., & Mills, G. B. (2010). A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers. Clinical proteomics, 6(4), 129-51. https://doi.org/10.1007/s12014-010-9055-y
Hennessy, Bryan T, et al. "A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers." Clinical proteomics vol. 6,4 (2010): 129-51. doi: https://doi.org/10.1007/s12014-010-9055-y
Hennessy BT, Lu Y, Gonzalez-Angulo AM, Carey MS, Myhre S, Ju Z, Davies MA, Liu W, Coombes K, Meric-Bernstam F, Bedrosian I, McGahren M, Agarwal R, Zhang F, Overgaard J, Alsner J, Neve RM, Kuo WL, Gray JW, Borresen-Dale AL, Mills GB. A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers. Clin Proteomics. 2010 Dec;6(4):129-51. doi: 10.1007/s12014-010-9055-y. PMID: 21691416; PMCID: PMC3116520.
Copy Download .nbib Format: NLM
Personalized cancer care conference.

Journal of personalized medicine

Zänker KS, Mihich E, Huber HP, Borresen-Dale AL.
PMID: 25562519
J Pers Med. 2013 Apr 29;3(2):70-81. doi: 10.3390/jpm3020070.

The Oslo University Hospital (Norway), the K.G. Jebsen Centre for Breast Cancer Research (Norway), The Radiumhospital Foundation (Norway) and the Fritz-Bender-Foundation (Germany) designed under the conference chairmen (E. Mihich, K.S. Zänker, A.L. Borresen-Dale) and advisory committee (A. Borg, Z....

Cite
Zänker KS, Mihich E, Huber HP, et al. Personalized cancer care conference. J Pers Med. 2013;3(2):70-81doi: 10.3390/jpm3020070.
Zänker, K. S., Mihich, E., Huber, H. P., & Borresen-Dale, A. L. (2013). Personalized cancer care conference. Journal of personalized medicine, 3(2), 70-81. https://doi.org/10.3390/jpm3020070
Zänker, Kurt S, et al. "Personalized cancer care conference." Journal of personalized medicine vol. 3,2 (2013): 70-81. doi: https://doi.org/10.3390/jpm3020070
Zänker KS, Mihich E, Huber HP, Borresen-Dale AL. Personalized cancer care conference. J Pers Med. 2013 Apr 29;3(2):70-81. doi: 10.3390/jpm3020070. PMID: 25562519; PMCID: PMC4251400.
Copy Download .nbib Format: NLM
Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.

Genome research

Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M, Li Y, Yates L, Gundem G, Tarpey PS, Behjati S, Papaemmanuil E, Martin S, Fullam A, Gerstung M, Nangalia J, Green AR, Caldas C, Borg Å, Tutt A, Lee MT, Van't Veer LJ, Tan BK, Aparicio S, Span PN, Martens JW, Knappskog S, Vincent-Salomon A, Børresen-Dale AL, Eyfjörd JE, Myklebost O, Flanagan AM, Foster C, Neal DE, Cooper C, Eeles R, Bova GS, Lakhani SR, Desmedt C, Thomas G, Richardson AL, Purdie CA, Thompson AM, McDermott U, Yang F, Nik-Zainal S, Campbell PJ, Stratton MR.
PMID: 27197245
Genome Res. 2016 May;26(5):717.2. doi: 10.1101/gr.206557.116.

No abstract available.

Cite
Ju YS, Tubio JM, Mifsud W, et al. Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome Res. 2016;26(5):717.2doi: 10.1101/gr.206557.116.
Ju, Y. S., Tubio, J. M., Mifsud, W., Fu, B., Davies, H. R., Ramakrishna, M., Li, Y., Yates, L., Gundem, G., Tarpey, P. S., Behjati, S., Papaemmanuil, E., Martin, S., Fullam, A., Gerstung, M., Nangalia, J., Green, A. R., Caldas, C., Borg, �. �., Tutt, A., Lee, M. T., Van't Veer, L. J., Tan, B. K., Aparicio, S., Span, P. N., Martens, J. W., Knappskog, S., Vincent-Salomon, A., Børresen-Dale, A. L., Eyfjörd, J. E., Myklebost, O., Flanagan, A. M., Foster, C., Neal, D. E., Cooper, C., Eeles, R., Bova, G. S., Lakhani, S. R., Desmedt, C., Thomas, G., Richardson, A. L., Purdie, C. A., Thompson, A. M., McDermott, U., Yang, F., Nik-Zainal, S., Campbell, P. J., & Stratton, M. R. (2016). Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome research, 26(5), 717.2. https://doi.org/10.1101/gr.206557.116
Ju, Young Seok, et al. "Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells." Genome research vol. 26,5 (2016): 717.2. doi: https://doi.org/10.1101/gr.206557.116
Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M, Li Y, Yates L, Gundem G, Tarpey PS, Behjati S, Papaemmanuil E, Martin S, Fullam A, Gerstung M, Nangalia J, Green AR, Caldas C, Borg Å, Tutt A, Lee MT, Van't Veer LJ, Tan BK, Aparicio S, Span PN, Martens JW, Knappskog S, Vincent-Salomon A, Børresen-Dale AL, Eyfjörd JE, Myklebost O, Flanagan AM, Foster C, Neal DE, Cooper C, Eeles R, Bova GS, Lakhani SR, Desmedt C, Thomas G, Richardson AL, Purdie CA, Thompson AM, McDermott U, Yang F, Nik-Zainal S, Campbell PJ, Stratton MR. Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome Res. 2016 May;26(5):717.2. doi: 10.1101/gr.206557.116. PMID: 27197245; PMCID: PMC4864453.
Copy Download .nbib Format: NLM
Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis.

BMC genomics

Zhao H, Hastie T, Whitfield ML, Børresen-Dale AL, Jeffrey SS.
PMID: 12445333
BMC Genomics. 2002 Oct 30;3(1):31. doi: 10.1186/1471-2164-3-31. Epub 2002 Oct 30.

BACKGROUND: T7 based linear amplification of RNA is used to obtain sufficient antisense RNA for microarray expression profiling. We optimized and systematically evaluated the fidelity and reproducibility of different amplification protocols using total RNA obtained from primary human breast...

Cite
Zhao H, Hastie T, Whitfield ML, et al. Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis. BMC Genomics. 2002;3(1):31doi: 10.1186/1471-2164-3-31.
Zhao, H., Hastie, T., Whitfield, M. L., Børresen-Dale, A. L., & Jeffrey, S. S. (2002). Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis. BMC genomics, 3(1), 31. https://doi.org/10.1186/1471-2164-3-31
Zhao, Hongjuan, et al. "Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis." BMC genomics vol. 3,1 (2002): 31. doi: https://doi.org/10.1186/1471-2164-3-31
Zhao H, Hastie T, Whitfield ML, Børresen-Dale AL, Jeffrey SS. Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis. BMC Genomics. 2002 Oct 30;3(1):31. doi: 10.1186/1471-2164-3-31. Epub 2002 Oct 30. PMID: 12445333; PMCID: PMC137577.
Copy Download .nbib Format: NLM
Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes.

Cancer & metabolism

Haukaas TH, Euceda LR, Giskeødegård GF, Lamichhane S, Krohn M, Jernström S, Aure MR, Lingjærde OC, Schlichting E, Garred Ø, Due EU, Mills GB, Sahlberg KK, Børresen-Dale AL, Bathen TF.
PMID: 27350877
Cancer Metab. 2016 Jun 27;4:12. doi: 10.1186/s40170-016-0152-x. eCollection 2016.

BACKGROUND: The heterogeneous biology of breast cancer leads to high diversity in prognosis and response to treatment, even for patients with similar clinical diagnosis, histology, and stage of disease. Identifying mechanisms contributing to this heterogeneity may reveal new cancer...

Cite
Haukaas TH, Euceda LR, Giskeødegård GF, et al. Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes. Cancer Metab. 2016;4:12doi: 10.1186/s40170-016-0152-x.
Haukaas, T. H., Euceda, L. R., Giskeødegård, G. F., Lamichhane, S., Krohn, M., Jernström, S., Aure, M. R., Lingjærde, O. C., Schlichting, E., Garred, �. �., Due, E. U., Mills, G. B., Sahlberg, K. K., Børresen-Dale, A. L., Bathen, T. F. (2016). Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes. Cancer & metabolism, 412. https://doi.org/10.1186/s40170-016-0152-x
Haukaas, Tonje H, et al. "Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes." Cancer & metabolism vol. 4 (2016): 12. doi: https://doi.org/10.1186/s40170-016-0152-x
Haukaas TH, Euceda LR, Giskeødegård GF, Lamichhane S, Krohn M, Jernström S, Aure MR, Lingjærde OC, Schlichting E, Garred Ø, Due EU, Mills GB, Sahlberg KK, Børresen-Dale AL, Bathen TF. Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes. Cancer Metab. 2016 Jun 27;4:12. doi: 10.1186/s40170-016-0152-x. eCollection 2016. PMID: 27350877; PMCID: PMC4922058.
Copy Download .nbib Format: NLM
Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer.

Genome medicine

Aure MR, Jernström S, Krohn M, Vollan HK, Due EU, Rødland E, Kåresen R, Ram P, Lu Y, Mills GB, Sahlberg KK, Børresen-Dale AL, Lingjærde OC, Kristensen VN.
PMID: 25873999
Genome Med. 2015 Feb 02;7(1):21. doi: 10.1186/s13073-015-0135-5. eCollection 2015.

BACKGROUND: The role played by microRNAs in the deregulation of protein expression in breast cancer is only partly understood. To gain insight, the combined effect of microRNA and mRNA expression on protein expression was investigated in three independent data...

Cite
Aure MR, Jernström S, Krohn M, et al. Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer. Genome Med. 2015;7(1):21doi: 10.1186/s13073-015-0135-5.
Aure, M. R., Jernström, S., Krohn, M., Vollan, H. K., Due, E. U., Rødland, E., Kåresen, R., Ram, P., Lu, Y., Mills, G. B., Sahlberg, K. K., Børresen-Dale, A. L., Lingjærde, O. C., & Kristensen, V. N. (2015). Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer. Genome medicine, 7(1), 21. https://doi.org/10.1186/s13073-015-0135-5
Aure, Miriam Ragle, et al. "Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer." Genome medicine vol. 7,1 (2015): 21. doi: https://doi.org/10.1186/s13073-015-0135-5
Aure MR, Jernström S, Krohn M, Vollan HK, Due EU, Rødland E, Kåresen R, Ram P, Lu Y, Mills GB, Sahlberg KK, Børresen-Dale AL, Lingjærde OC, Kristensen VN. Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer. Genome Med. 2015 Feb 02;7(1):21. doi: 10.1186/s13073-015-0135-5. eCollection 2015. PMID: 25873999; PMCID: PMC4396592.
Copy Download .nbib Format: NLM
Next-generation sequencing of disseminated tumor cells.

Frontiers in oncology

Møller EK, Kumar P, Voet T, Peterson A, Van Loo P, Mathiesen RR, Fjelldal R, Grundstad J, Borgen E, Baumbusch LO, Naume B, Børresen-Dale AL, White KP, Nord S, Kristensen VN.
PMID: 24427740
Front Oncol. 2013 Dec 31;3:320. doi: 10.3389/fonc.2013.00320. eCollection 2013.

Disseminated tumor cells (DTCs) detected in the bone marrow have been shown as an independent prognostic factor for women with breast cancer. However, the mechanisms behind the tumor cell dissemination are still unclear and more detailed knowledge is needed...

Cite
Møller EK, Kumar P, Voet T, et al. Next-generation sequencing of disseminated tumor cells. Front Oncol. 2013;3:320doi: 10.3389/fonc.2013.00320.
Møller, E. K., Kumar, P., Voet, T., Peterson, A., Van Loo, P., Mathiesen, R. R., Fjelldal, R., Grundstad, J., Borgen, E., Baumbusch, L. O., Naume, B., Børresen-Dale, A. L., White, K. P., Nord, S., & Kristensen, V. N. (2013). Next-generation sequencing of disseminated tumor cells. Frontiers in oncology, 3320. https://doi.org/10.3389/fonc.2013.00320
Møller, Elen K, et al. "Next-generation sequencing of disseminated tumor cells." Frontiers in oncology vol. 3 (2013): 320. doi: https://doi.org/10.3389/fonc.2013.00320
Møller EK, Kumar P, Voet T, Peterson A, Van Loo P, Mathiesen RR, Fjelldal R, Grundstad J, Borgen E, Baumbusch LO, Naume B, Børresen-Dale AL, White KP, Nord S, Kristensen VN. Next-generation sequencing of disseminated tumor cells. Front Oncol. 2013 Dec 31;3:320. doi: 10.3389/fonc.2013.00320. eCollection 2013. PMID: 24427740; PMCID: PMC3876274.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 33 entries